This report is based on the summer training undertaken with lupin ltd anleshwar. It will be beneficial to the students who appear for training with lupin ankleshwar. The report also contains mini project on job rotation and transfer.
This is the report of my first Summer training in BBA at Lupin, Ankleshwar plant. This whole report is prepared by me with the help of information provided by the company. Production, Dispatch, Store-warehouse, Purchase, Financial, HR departments are included in this project.
This project also include a Mini Project on "Job Satisfaction". I complete this project with the help of Random Survey method. I hop this report will help you in your study.
For any kind of query or correction in the project contact me through
email- rajat.gandhi27@gmail.com
facebook- www.facebook.com/rajat.gandhi28
This report is based on the summer training undertaken with lupin ltd anleshwar. It will be beneficial to the students who appear for training with lupin ankleshwar. The report also contains mini project on job rotation and transfer.
This is the report of my first Summer training in BBA at Lupin, Ankleshwar plant. This whole report is prepared by me with the help of information provided by the company. Production, Dispatch, Store-warehouse, Purchase, Financial, HR departments are included in this project.
This project also include a Mini Project on "Job Satisfaction". I complete this project with the help of Random Survey method. I hop this report will help you in your study.
For any kind of query or correction in the project contact me through
email- rajat.gandhi27@gmail.com
facebook- www.facebook.com/rajat.gandhi28
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...sridivyaannavarapu
THE INDIAN GOVERNMENT HAS STARTED TO ENCOURAGE THE GROWTH OF DRUG MANUFACTURING BY INDIAN COMPANIES IN THE EARLY 1960s. AT PRESENT THERE ARE MANY NUMBER OF PHARMACEUTICAL COMPANIES IN INDIA WITH MANY NOVEL DRUG INVENTORIES
Sun pharma- A complete company review, analysis of crisis and realistic recom...TilikaChawda
Sun pharma has been the most talked about Indian pharma company for being in the news several times for its unresolved issues with the US FDA regarding the Halol and Mohali plant.
This presentation has analysed the situation and it suggests various solutions for the same.
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...sridivyaannavarapu
THE INDIAN GOVERNMENT HAS STARTED TO ENCOURAGE THE GROWTH OF DRUG MANUFACTURING BY INDIAN COMPANIES IN THE EARLY 1960s. AT PRESENT THERE ARE MANY NUMBER OF PHARMACEUTICAL COMPANIES IN INDIA WITH MANY NOVEL DRUG INVENTORIES
Sun pharma- A complete company review, analysis of crisis and realistic recom...TilikaChawda
Sun pharma has been the most talked about Indian pharma company for being in the news several times for its unresolved issues with the US FDA regarding the Halol and Mohali plant.
This presentation has analysed the situation and it suggests various solutions for the same.
15 Stats Every Marketing Leader Needs to KnowHubSpot
Benchmark your company's performance against stats from hundreds of other marketers around email performance, cost per lead, popular marketing tactics, revenue attainment, and more. All stats are taken from our 2017 Demand Generation Benchmarks Report: http://hubs.ly/H08nwvl0
an assignment on business level strategies and its impact on the performance of an industrial company in bangladesh: a case study on square pharmaceuticals limited
PHARMACEUTICAL VETERAN MR. SHANTANU SINGH ASSUMES CFO TAJ PHARMA AS MR. SHANT...Shantanu Kumar Singh
Mumbai Based Shnatanu Kumar Singh Taj Pharma [Director Executive] | Taj Pharmaceuticals {Taj Pharma}Shantanu Taj Pharma [Director] | Taj Pharmaceuticals PHARMACEUTICAL VETERAN MR. SHANTANU SINGH ASSUMES CFO TAJ PHARMA AS ... MR. SHANTANU KUMAR SINGH — TAJ PHARMACEUTICALS LTD. Mumbai Based Shnatanu Kumar Singh Taj Pharma [Director Executive] | Taj Pharmaceuticals Mr. Shantanu Kumar(Shan) Singh has been appointed by the Board as the new CFO, effective August 1, 2018. Mr. Shantanu Singh is currently the Executive Director of Inovm pharma Inc. and most recently was the CEO of xenon-nanodrugs GmbH, based in Munich, Germany. Prior to that he was the Executive Director of Taj Pharmaceuticals, and has over 10 years business experience that includes senior leadership roles at Taj Ago, Taj Api, Morgan Stanley and Deutsche Bank.
Personal Brand Statement:
As an Army veteran dedicated to lifelong learning, I bring a disciplined, strategic mindset to my pursuits. I am constantly expanding my knowledge to innovate and lead effectively. My journey is driven by a commitment to excellence, and to make a meaningful impact in the world.
Discover the innovative and creative projects that highlight my journey throu...dylandmeas
Discover the innovative and creative projects that highlight my journey through Full Sail University. Below, you’ll find a collection of my work showcasing my skills and expertise in digital marketing, event planning, and media production.
The world of search engine optimization (SEO) is buzzing with discussions after Google confirmed that around 2,500 leaked internal documents related to its Search feature are indeed authentic. The revelation has sparked significant concerns within the SEO community. The leaked documents were initially reported by SEO experts Rand Fishkin and Mike King, igniting widespread analysis and discourse. For More Info:- https://news.arihantwebtech.com/search-disrupted-googles-leaked-documents-rock-the-seo-world/
What are the main advantages of using HR recruiter services.pdfHumanResourceDimensi1
HR recruiter services offer top talents to companies according to their specific needs. They handle all recruitment tasks from job posting to onboarding and help companies concentrate on their business growth. With their expertise and years of experience, they streamline the hiring process and save time and resources for the company.
Putting the SPARK into Virtual Training.pptxCynthia Clay
This 60-minute webinar, sponsored by Adobe, was delivered for the Training Mag Network. It explored the five elements of SPARK: Storytelling, Purpose, Action, Relationships, and Kudos. Knowing how to tell a well-structured story is key to building long-term memory. Stating a clear purpose that doesn't take away from the discovery learning process is critical. Ensuring that people move from theory to practical application is imperative. Creating strong social learning is the key to commitment and engagement. Validating and affirming participants' comments is the way to create a positive learning environment.
Improving profitability for small businessBen Wann
In this comprehensive presentation, we will explore strategies and practical tips for enhancing profitability in small businesses. Tailored to meet the unique challenges faced by small enterprises, this session covers various aspects that directly impact the bottom line. Attendees will learn how to optimize operational efficiency, manage expenses, and increase revenue through innovative marketing and customer engagement techniques.
Implicitly or explicitly all competing businesses employ a strategy to select a mix
of marketing resources. Formulating such competitive strategies fundamentally
involves recognizing relationships between elements of the marketing mix (e.g.,
price and product quality), as well as assessing competitive and market conditions
(i.e., industry structure in the language of economics).
Skye Residences | Extended Stay Residences Near Toronto Airportmarketingjdass
Experience unparalleled EXTENDED STAY and comfort at Skye Residences located just minutes from Toronto Airport. Discover sophisticated accommodations tailored for discerning travelers.
Website Link :
https://skyeresidences.com/
https://skyeresidences.com/about-us/
https://skyeresidences.com/gallery/
https://skyeresidences.com/rooms/
https://skyeresidences.com/near-by-attractions/
https://skyeresidences.com/commute/
https://skyeresidences.com/contact/
https://skyeresidences.com/queen-suite-with-sofa-bed/
https://skyeresidences.com/queen-suite-with-sofa-bed-and-balcony/
https://skyeresidences.com/queen-suite-with-sofa-bed-accessible/
https://skyeresidences.com/2-bedroom-deluxe-queen-suite-with-sofa-bed/
https://skyeresidences.com/2-bedroom-deluxe-king-queen-suite-with-sofa-bed/
https://skyeresidences.com/2-bedroom-deluxe-queen-suite-with-sofa-bed-accessible/
#Skye Residences Etobicoke, #Skye Residences Near Toronto Airport, #Skye Residences Toronto, #Skye Hotel Toronto, #Skye Hotel Near Toronto Airport, #Hotel Near Toronto Airport, #Near Toronto Airport Accommodation, #Suites Near Toronto Airport, #Etobicoke Suites Near Airport, #Hotel Near Toronto Pearson International Airport, #Toronto Airport Suite Rentals, #Pearson Airport Hotel Suites
Tata Group Dials Taiwan for Its Chipmaking Ambition in Gujarat’s DholeraAvirahi City Dholera
The Tata Group, a titan of Indian industry, is making waves with its advanced talks with Taiwanese chipmakers Powerchip Semiconductor Manufacturing Corporation (PSMC) and UMC Group. The goal? Establishing a cutting-edge semiconductor fabrication unit (fab) in Dholera, Gujarat. This isn’t just any project; it’s a potential game changer for India’s chipmaking aspirations and a boon for investors seeking promising residential projects in dholera sir.
Visit : https://www.avirahi.com/blog/tata-group-dials-taiwan-for-its-chipmaking-ambition-in-gujarats-dholera/
[Note: This is a partial preview. To download this presentation, visit:
https://www.oeconsulting.com.sg/training-presentations]
Sustainability has become an increasingly critical topic as the world recognizes the need to protect our planet and its resources for future generations. Sustainability means meeting our current needs without compromising the ability of future generations to meet theirs. It involves long-term planning and consideration of the consequences of our actions. The goal is to create strategies that ensure the long-term viability of People, Planet, and Profit.
Leading companies such as Nike, Toyota, and Siemens are prioritizing sustainable innovation in their business models, setting an example for others to follow. In this Sustainability training presentation, you will learn key concepts, principles, and practices of sustainability applicable across industries. This training aims to create awareness and educate employees, senior executives, consultants, and other key stakeholders, including investors, policymakers, and supply chain partners, on the importance and implementation of sustainability.
LEARNING OBJECTIVES
1. Develop a comprehensive understanding of the fundamental principles and concepts that form the foundation of sustainability within corporate environments.
2. Explore the sustainability implementation model, focusing on effective measures and reporting strategies to track and communicate sustainability efforts.
3. Identify and define best practices and critical success factors essential for achieving sustainability goals within organizations.
CONTENTS
1. Introduction and Key Concepts of Sustainability
2. Principles and Practices of Sustainability
3. Measures and Reporting in Sustainability
4. Sustainability Implementation & Best Practices
To download the complete presentation, visit: https://www.oeconsulting.com.sg/training-presentations
Digital Transformation and IT Strategy Toolkit and TemplatesAurelien Domont, MBA
This Digital Transformation and IT Strategy Toolkit was created by ex-McKinsey, Deloitte and BCG Management Consultants, after more than 5,000 hours of work. It is considered the world's best & most comprehensive Digital Transformation and IT Strategy Toolkit. It includes all the Frameworks, Best Practices & Templates required to successfully undertake the Digital Transformation of your organization and define a robust IT Strategy.
Editable Toolkit to help you reuse our content: 700 Powerpoint slides | 35 Excel sheets | 84 minutes of Video training
This PowerPoint presentation is only a small preview of our Toolkits. For more details, visit www.domontconsulting.com
Business Valuation Principles for EntrepreneursBen Wann
This insightful presentation is designed to equip entrepreneurs with the essential knowledge and tools needed to accurately value their businesses. Understanding business valuation is crucial for making informed decisions, whether you're seeking investment, planning to sell, or simply want to gauge your company's worth.
Torrent pharmaceuticals ltd. by sushain mahajan to tafheen si rpptx
1. TORRENT PHARMACEUTICALS LTD.
Business Statistics
and Quantitative
Technique Submission to : Mr. Tafheem
Submission by : Sushain Mahajan
MBA (PM), 2nd
Semester
2. INDEX
Introduction.
History.
Mission , Vision and Values.
List of API’s Manufactured.
Analysis of Profits with specific calculations
using business statistics.
3. INTRODUCTION OF COMPANY:
Torrent Pharma is in the Pharmaceuticals sector.
Torrent Pharmaceuticals Ltd. is the flagship company
of the Torrent Group.
Based in Ahmedabad , it was promoted by U. N.
Mehta initially as Trinity Laboratories Ltd. and was
later renamed to its current name Torrent
Pharmaceuticals Ltd.
Torrent Pharmaceuticals operates in more than 50
countries with over 1000 product registrations
globally.
The current market capitalisation stands at Rs
21,510.75 crore.
4. COMPANY MANAGEMENT INCLUDES:
• Ashish
Nanda,
• Bhavna
Doshi
• Samir
Mehra
• Markand
Bhatt,
• Pradeep
Bhargava,
• Shailesh
Haribhakti
• Sudhir
Mehta
Chairman Director
Independ
ent
Director
Executive
Vice
Chairman
5. HISTORY:
1972 - The Company was incorporated on 15th July, as a Private Limited
Company by Shri Rajnikant C. Patel and his family members, and in June 1982,
the company was acquired by Shri Uttamlal N. Mehta.
1989 - On 28th June the Company became a deemed Public Company under
the provisions of Section 43-A of the Act and by a Special Resolution passed on
25th July, 1992 at the Annual General Meeting, the Company became a Public
Limited Company within the meaning of Section 3(1)(iv) of the act and adopted a
new set of articles.
1992 - Torrent Laboratories Limited, was amalgamated with the Company with
effect from 1st April by an order of the Honourable High Court of Gujarat, dated
22nd December.
1993 - The Company proposes to modernize its present manufacturing facilities
located at Vatva and Chhatral to conform to the GMP requirements as also to
incorporate the latest technology available in the field.
6. During the year, Torrent Medi-Systems Limited (TMSL) was merged with the
Company with effect from 1st April consequent to the scheme of amalgamation
approved by the Honourable High Court of Gujarat.
1994 - The Company issued 1,74,144 Equity Shares of Rs.10 each as fully paid
up shares to the shareholders of TMSL after cancelling 9,300 Shares held by the
Company in TMSL.
The Company was the first to launch ranitidine (Ranitin), nifedipine (Calcigard,)
atenolol (Betacard), domperidone (Domstal), diltiazem (Dilzem), amiodorane
(Cordarone), Lisinopril (Listril), etc. in the Indian market.
During the year the Company launched a number of new products like Zirtin,
Tyklid, Flutamide and Topcef, all of which were well received in the market place.
1995 - During the year the Company launched a number of new products like
Lomef (Lomefloxacin), Dilzem Inj. (Diltiazem), Depidol LA (Haliiperidiil
Decanoate) Oncoden (Ondancetron), Nimotide (Nimodipne), Pefcin (Pefloxacin)
which have gained wide acceptance in the pharmaceutical market.
7. 1999 - Among the new products launched recently included Nikoran IV for
critical care in cardiology and a novel drug approved for launch in the anti-
epileptic category.
2002 - Torrent Pharma’s manufacturing facilities certified with ISO 14001:1996.
Torrent’s R&D Centre received ISO/IEC 17025:1999 for its facilities by National
Accreditation Board for Testing and Calibration Laboratories (NABL).
2003 - Torrent Pharma sets up a wholly owned subsidiaries in Germany and
Brazil.
2004 - Torrent Pharmaceuticals Limited (TPL) has signed a non-exclusive
agreement with Dr. Reddy's Laboratories Limited (DRL) for licensing and
supplying the formulation of one of Torrent's blockbuster drug 'Domstal O' in the
Gastro Intestinal segment
8. 2005 - Torrent Pharmaceuticals signs agreement with Novo Nordisk,
Denmark to establish new, dedicated formulation and packaging facility
for Insulin, exclusively for Novo Nordisk.
2006 - Torrent Pharma Receives USFDA Approval. Torrent’s Azuca
launches 2 new blockbusters, Pregeb and Piopod.
2010 - The Board has recommended a dividend of Rs. 6.00 per equity
share having face value of Rs. 5/- each.
2012 - The Board has appointed Haigreve khaitan as Additional Director.
The Board has recommended a final dividend of Rs. 2.50 per equity
share.
14. ANALYSIS OF PROFITS:
Following Financial Reports are used for the
analysis of profits of Torrent Pharmaceuticals
Ltd.
Quarter Ended
June 2013
Quarter Ended
September
2013
Quarter Ended
December
2013
Quarter Ended
March 2014
Quarter Ended
June 2014
Quarter Ended
September
2014
Quarter Ended
December
2014
17. MEASURES OF CENTRAL TENDENCIES:
A measure of central tendency is a single value that
attempts to describe a set of data by identifying the
central position within that set of data.
As such, measures of central tendency are sometimes
called measures of central location.
They are also classed as summary statistics.
The mean (often called the average) is most likely the
measure of central tendency that you are most familiar
with, but there are others, such as the median and the
mode.
18. • The mean is equal to the sum of all
the values in the data set divided by
the number of values in the data set.
Mean:
• total no. of sample and ‘X’ correspond
to the observed valued.
Formula of mean is:
19. • The median is the middle score for a set
of data.
• When there is an odd number of
numbers, the median is simply the middle
number.
Median:
• Where ‘n’ is the number of samples
Formula of Median is:
20. • Mode of a set of data is the number with
the highest frequency.
Mode:
• A statistic used as a measure of the
dispersion or variation in a distribution or
set of data, equal to the square root of
the arithmetic mean of the squares of the
deviations from the arithmetic mean.
Standard Deviation:
22. • => 149+113+158+224+256+198+167
7
=> 1265
7
=> 180.71
Therefore, the mean profit of
Torrent Pharmaceuticals Ltd. in 7
quarters is Rs. 180.71 crores.
• Profit : Rs. 149 crores
Quarter Ended June 2013
• Profit : Rs. 113 crores
Quarter Ended September
2013
• Profit : Rs. 158 crores
Quarter Ended December
2013
•Profit : Rs. 224 crores
Quarter Ended March 2014
•Profit : Rs. 256 crores
Quarter Ended June 2014
•Profit : Rs. 198 crores
Quarter Ended September 2014
•Profit : Rs. 167 crores
Quarter Ended December 2014
23. • Data in ascending order :
113,149,158,167,198,224,256
• [(n+1)/2]th data
• [ (7+1)/2]th = 4th observation
• 167 (Rs. in crores)
Therefore, the Median is Rs. 167
crores.
• Profit : Rs. 149 crores
Quarter Ended June 2013
• Profit : Rs. 113 crores
Quarter Ended September
2013
• Profit : Rs. 158 crores
Quarter Ended December
2013
•Profit : Rs. 224 crores
Quarter Ended March 2014
•Profit : Rs. 256 crores
Quarter Ended June 2014
•Profit : Rs. 198 crores
Quarter Ended September 2014
•Profit : Rs. 167 crores
Quarter Ended December 2014
24. • The mode of a set of data is the
number with highest frequency,
here there is no repetition.
Therefore, there is no Mode.
• Profit : Rs. 149 crores
Quarter Ended June 2013
• Profit : Rs. 113 crores
Quarter Ended September
2013
• Profit : Rs. 158 crores
Quarter Ended December
2013
•Profit : Rs. 224 crores
Quarter Ended March 2014
•Profit : Rs. 256 crores
Quarter Ended June 2014
•Profit : Rs. 198 crores
Quarter Ended September 2014
•Profit : Rs. 167 crores
Quarter Ended December 2014
25. Therefore, the standard
deviation is Rs. 48.53 crores.
• Profit : Rs. 149 crores
Quarter Ended June 2013
• Profit : Rs. 113 crores
Quarter Ended September
2013
• Profit : Rs. 158 crores
Quarter Ended December
2013
•Profit : Rs. 224 crores
Quarter Ended March 2014
•Profit : Rs. 256 crores
Quarter Ended June 2014
•Profit : Rs. 198 crores
Quarter Ended September 2014
•Profit : Rs. 167 crores
Quarter Ended December 2014
26. BUSINESS IMPLICATION:
Torrent Pharmaceuticals Ltd. have average
of Rs. 180.71 crores of profit after the
calculation.
Torrent Pharmaceuticals Ltd. highest profits
has been Rs. 256 crores while lowest profit
has been Rs. 113 crores.
